Name | tert-Butyl 3-(2-(tert-butoxy)-2-oxoethyl)-4-oxopiperidine-1-carboxylate |
---|---|
Synonyms |
tert-butyl 3-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-4-oxopiperidine-1-carboxylate
2-Methyl-2-propanyl 3-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-4-oxo-1-piperidinecarboxylate 3-Piperidineacetic acid, 1-[(1,1-dimethylethoxy)carbonyl]-4-oxo-, 1,1-dimethylethyl ester |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 396.6±27.0 °C at 760 mmHg |
Molecular Formula | C16H27NO5 |
Molecular Weight | 313.389 |
Flash Point | 193.6±23.7 °C |
Exact Mass | 313.188934 |
PSA | 72.91000 |
LogP | 1.77 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.475 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933399090 |
~50% 1010814-94-4 |
Literature: ACTELION PHARMACEUTICALS LTD Patent: WO2008/26172 A1, 2008 ; Location in patent: Page/Page column 63 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |